Investor Presentaiton
REVENUE PERFORMANCE BY CHANNEL
(in millions of Canadian dollars, unaudited)
Q2 FY2024
Q2 FY2023
(As Restated)
VS.
Q2 FY2024
Canadian Recreational Cannabis Net Revenue
Business-to-business¹
$24.0
$25.3
(5)%
Business-to-consumer
$ -
$12.8
(100)%
$24.0
$38.1
(37)%
Canadian Medical Cannabis Net Revenue²
$15.0
$14.2
6%
$39.0
$52.3
(25)%
Rest-of-world cannabis³
$9.0
$10.5
(14)%
Storz & Bickel
$12.0
$13.5
(11%)
This Works
$7.1
$6.9
3%
Other
$2.5
$4.7
(47)%
Net Revenue
$69.6
$87.9
(21%)
1 For Q2 FY2024, amount is net of excise taxes of $10.8 MM and other revenue adjustments of $0.5 MM (Q2 FY2023 - $11.4 MM and $0.4 MM, respectively).
2 For Q2 FY2024, amount is net of excise taxes of $1.7 MM (Q2 FY2023 - $1.1 MM).
3 For Q2 FY2024, amount reflects other revenue adjustments of $0.1 MM (Q2 FY2023 - $0.5 MM).
17View entire presentation